Search
for
Sort by
Research 811–840 of 1000+
- Gender aspects in skin diseases
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Regulation of masculinization: androgen signalling for external genitalia development
- Mitoxantrone
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Autophagy is essential for maintaining the growth of a human (mini-)organ: Evidence from scalp hair follicle organ culture
- The Role of Extracellular Vesicles in Cutaneous Remodeling and Hair Follicle Dynamics
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Epigenetic control of skin and hair regeneration after wounding
- Skin and hair: models for exploring organ regeneration
- Azelaic Acid: Mechanisms of Action and Clinical Applications
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Regulatory T cells are required for normal and activin‐promoted wound repair in mice
- Biochemistry of epidermal stem cells
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- CD10 and CD34 in fetal and adult human hair follicles: dynamic changes in their immunohistochemical expression during embryogenesis and hair cycling
- <i>Pten</i> loss in Lgr5<sup>+</sup> hair follicle stem cells promotes SCC development
- Nutrition and the deleterious side effects of nutritional supplements
- Hair Loss in Systemic Disease
- Cicatricial alopecia
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)
- The dermatological consequences of obesity
- Scalp Flaps
- The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds)
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Skin diseases in consequence of endocrine alterations
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy